{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T10:45:52Z","timestamp":1791456352274,"version":"4.3.4"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,3,1]]},"DOI":"10.1097\/qai.0b013e3181b67527","type":"journal-article","created":{"date-parts":[[2010,2,24]],"date-time":"2010-02-24T08:32:45Z","timestamp":1267000365000},"page":"388-396","source":"Crossref","is-referenced-by-count":44,"title":["Trends in Hepatitis C Virus Infection Among Patients in the HIV Outpatient Study, 1996\u20132007"],"prefix":"10.1097","volume":"53","author":[{"given":"Philip R","family":"Spradling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Buchacz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne C","family":"Moorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyn","family":"Finelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth P","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210131","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1086\/318501","article-title":"Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus.","volume":"32","author":"Bica","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R2-14-20210131","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1086\/321819","article-title":"Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection.","volume":"33","author":"Monga","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R3-14-20210131","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1086\/343862","article-title":"Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998.","volume":"186","author":"Louie","year":"2002","journal-title":"J Infect Dis"},{"key":"R4-14-20210131","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1097\/00002030-200308150-00009","article-title":"Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study).","volume":"17","author":"Rosenthal","year":"2003","journal-title":"AIDS"},{"key":"R5-14-20210131","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00126334-200309010-00015","article-title":"Recent trends in HIV-related inpatient admissions 1996-2000: a 7-state study.","volume":"34","author":"Fleishman","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R6-14-20210131","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ije\/dyh307","article-title":"Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy; emerging role of hepatitis and cancers, persistent role of AIDS.","volume":"34","author":"Lewden","year":"2005","journal-title":"Int J Epidemiol"},{"key":"R7-14-20210131","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/01.qai.0000171727.55553.78","article-title":"Hospitalizations for metabolic conditions, opportunistic infections, and injection drug use among HIV patients: trends between 1996 and 2000 in 12 states.","volume":"40","author":"Gebo","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R8-14-20210131","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jhep.2005.01.022","article-title":"Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol.","volume":"42","author":"Salmon-Ceron","year":"2005","journal-title":"J Hepatol"},{"key":"R9-14-20210131","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/jurban\/jtg074","article-title":"Mortality rates and causes of death in a cohort of HIV-infected and uninfected women, 1993-1999.","volume":"80","author":"Smith","year":"2005","journal-title":"J Urban Health"},{"key":"R10-14-20210131","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/01.qai.0000179459.31562.16","article-title":"Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras.","volume":"41","author":"Crum","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R11-14-20210131","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1086\/345953","article-title":"Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy.","volume":"36","author":"Tedaldi","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R12-14-20210131","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/hep.510310332","article-title":"The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States.","volume":"31","author":"Armstrong","year":"2000","journal-title":"Hepatology"},{"key":"R13-14-20210131","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2893.2006.00785.x","article-title":"Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States.","volume":"14","author":"Deuffic-Burban","year":"2007","journal-title":"J Viral Hepat"},{"key":"R14-14-20210131","doi-asserted-by":"crossref","first-page":"705","DOI":"10.7326\/0003-4819-144-10-200605160-00004","article-title":"The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.","volume":"144","author":"Armstrong","year":"2006","journal-title":"Ann Intern Med"},{"key":"R15-14-20210131","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.2105\/AJPH.90.10.1562","article-title":"Estimating future hepatitis C morbidity, mortality, and costs in the United States.","volume":"90","author":"Wong","year":"2000","journal-title":"Am J Public Health"},{"key":"R16-14-20210131","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1002\/hep.1840360705","article-title":"The burden of hepatitis C in the United States.","volume":"36","author":"Kim","year":"2002","journal-title":"Hepatology"},{"key":"R17-14-20210131","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2105\/AJPH.92.3.385","article-title":"Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities.","volume":"92","author":"Murrill","year":"2002","journal-title":"Am J Public Health"},{"key":"R18-14-20210131","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/BF01641432","article-title":"Correlation of hepatitis C virus antibodies with HIV-1 seropositivity in intravenous drug addicts.","volume":"18","author":"Huemer","year":"1990","journal-title":"Infection"},{"key":"R19-14-20210131","first-page":"427","article-title":"Hepatitis C infection in an HIV-1 positive military population.","volume":"5","author":"Malone","year":"1992","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R20-14-20210131","first-page":"2071","article-title":"Prevalence of hepatitis C and coinfection with HIV among United States veterans in the New York City metropolitan area.","volume":"97","author":"Brau","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 3","key":"R21-14-20210131","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1097\/01.aids.0000192077.11067.e5","article-title":"Relative prevalence of comorbidities and treatment contraindications in HIV-mono-infected and HIV\/HCV-coinfected veterans.","volume":"19","author":"Goulet","year":"2005","journal-title":"AIDS"},{"key":"R22-14-20210131","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1423-0410.1992.tb01170.x","article-title":"All exposed hemophiliacs have markers of HCV.","volume":"62","author":"Laurian","year":"1992","journal-title":"Vox Sang"},{"key":"R23-14-20210131","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.amjsurg.2006.07.008","article-title":"Human immunodeficiency virus and hepatitis testing and prevalence among surgical patients in an urban university hospital.","volume":"193","author":"Weiss","year":"2007","journal-title":"Am J Surg"},{"key":"R24-14-20210131","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1128\/JCM.31.5.1189-1193.1993","article-title":"Prevalence and significance of hepatitis C virus (HCV) viremia in HCV antibody-positive subjects from various populations.","volume":"31","author":"Francois","year":"1993","journal-title":"J Clin Microbiol"},{"issue":"Suppl 3","key":"R25-14-20210131","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/01.aids.0000192065.09281.01","article-title":"HIV, hepatitis C and HIV\/hepatitis C virus coinfection in vulnerable populations.","volume":"19","author":"Backus","year":"2005","journal-title":"AIDS"},{"issue":"pt 2","key":"R26-14-20210131","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.ajog.2005.07.002","article-title":"Prevalence of hepatitis B and C in pregnant women who are infected with human immunodeficiency virus.","volume":"193","author":"Santiago-Munoz","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R27-14-20210131","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1086\/339042","article-title":"Hepatitis C virus prevalence among patients coinfected with human immunodeficiency virus: a cross-sectional analysis of the U.S. Adult AIDS Clinical Trials Group.","volume":"34","author":"Sherman","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R28-14-20210131","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1086\/374841","article-title":"Prevalence and characteristics of hepatitis C virus coinfection in a human immunodeficiency virus clinical trials group: the Terry Beirn Community Programs for Clinical Research on AIDS.","volume":"36","author":"Tedaldi","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R29-14-20210131","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection.","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"R30-14-20210131","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1047-2797(99)00005-8","article-title":"Changing conditions and treatments in a dynamic cohort of ambulatory HIV patients: the HIV Outpatient Study (HOPS).","volume":"9","author":"Moorman","year":"1999","journal-title":"Ann Epidemiol"},{"key":"R32-14-20210131","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1053\/j.gastro.2009.02.006","article-title":"Evidence of a large, international network of international HCV transmission in HIV-positive men who have sex with men.","volume":"136","author":"Van de Laar","year":"2009","journal-title":"Gastroenterology"},{"key":"R33-14-20210131","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1086\/518796","article-title":"Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission.","volume":"196","author":"Van der Laar","year":"2007","journal-title":"J Infect Dis"},{"key":"R34-14-20210131","first-page":"150","article-title":"Hepatitis C in the HIV Atlanta VA Cohort Study.","volume":"29","author":"Staples","year":"1999","journal-title":"Clin Infect Dis"},{"key":"R35-14-20210131","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3109\/10826089809062214","article-title":"Hepatitis C transmission dynamics in injecting drug users.","volume":"33","author":"Hagan","year":"1998","journal-title":"Subst Use Misuse"},{"key":"R36-14-20210131","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00005792-199507000-00005","article-title":"Correlates of hepatitis C infection among injection drug users.","volume":"74","author":"Thomas","year":"1995","journal-title":"Medicine"},{"key":"R37-14-20210131","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1128\/JCM.35.12.3274-3277.1997","article-title":"Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland.","volume":"35","author":"Villano","year":"1997","journal-title":"J Clin Microbiol"},{"key":"R38-14-20210131","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/jmv.1890330307","article-title":"Prevalence of hepatitis C antibodies among patients infected with human immunodeficiency virus.","volume":"33","author":"Hayashi","year":"1991","journal-title":"J Med Virol"},{"key":"R39-14-20210131","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/clinids\/17.1.117","article-title":"Hepatitis C infection in patients infected with the human immunodeficiency virus.","volume":"17","author":"Quan","year":"1993","journal-title":"Clin Infect Dis"},{"key":"R40-14-20210131","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1086\/588297","article-title":"Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2005.","volume":"46","author":"Amon","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R41-14-20210131","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1001\/archinte.167.2.166","article-title":"Injection drug users in the United States, 1979-2002: an aging population.","volume":"167","author":"Armstrong","year":"2007","journal-title":"Arch Intern Med"},{"key":"R42-14-20210131","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJM199908193410802","article-title":"The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.","volume":"341","author":"Alter","year":"1999","journal-title":"N Engl J Med"},{"key":"R43-14-20210131","first-page":"681","article-title":"Trends in HIV\/AIDS diagnoses among men who have sex with men-33 states, 2001-2006.","volume":"57","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R44-14-20210131","first-page":"985","article-title":"Subpopulation estimates from the HIV incidence surveillance system-United States, 2006.","volume":"57","year":"2008","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R45-14-20210131","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1086\/321909","article-title":"Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis.","volume":"33","author":"Graham","year":"2001","journal-title":"Clin Infect Dis"},{"key":"R46-14-20210131","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.qai.0000233310.90484.16","article-title":"Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV Outpatient Study.","volume":"43","author":"Pallela","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R47-14-20210131","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/hep.510290311","article-title":"Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection.","volume":"29","author":"Villano","year":"1999","journal-title":"Hepatology"},{"key":"R48-14-20210131","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJM199212313272702","article-title":"The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic, non-A, non-B Hepatitis Study Team.","volume":"327","author":"Alter","year":"1992","journal-title":"N Engl J Med"},{"key":"R49-14-20210131","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/00042560-200104010-00008","article-title":"Effect of coexisting HIV-1 infection on the diagnosis and evaluation of hepatitis C virus.","volume":"26","author":"Bonacini","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R50-14-20210131","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00126334-200210010-00005","article-title":"Hepatitis C virus viremia in HIV-infected individuals with negative HCV antibody tests.","volume":"31","author":"George","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R51-14-20210131","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1128\/JCM.38.2.575-577.2000","article-title":"Screening for hepatitis C virus in human immunodeficiency virus-infected individuals.","volume":"38","author":"Thio","year":"2000","journal-title":"J Clin Microbiol"},{"key":"R52-14-20210131","first-page":"159","article-title":"Diagnostic testing for hepatitis C. Hepatitis C: State of the Art at the Millennium (part 2).","volume":"20","author":"Carithers","year":"2000","journal-title":"Semin Liver Dis"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00126334-201003010-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T21:26:02Z","timestamp":1739913962000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-201003010-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,1]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e3181b67527","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3,1]]}}}